Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Cosmos Health - 15 Year Stock Price History | COSM

Historical daily share price chart and data for Cosmos Health since 2010 adjusted for splits and dividends. The latest closing stock price for Cosmos Health as of June 05, 2025 is 0.46.
  • The all-time high Cosmos Health stock closing price was 337.50 on March 13, 2014.
  • The Cosmos Health 52-week high stock price is 1.58, which is 243.5% above the current share price.
  • The Cosmos Health 52-week low stock price is 0.28, which is 39.1% below the current share price.
  • The average Cosmos Health stock price for the last 52 weeks is 0.75.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Cosmos Health Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.5298 0.6860 0.9300 0.3176 0.4580 -31.54%
2024 0.8623 1.3700 1.4600 0.4838 0.6690 -52.55%
2023 2.6324 5.5200 6.8200 0.9900 1.4100 -69.08%
2022 29.4652 95.0000 96.0000 1.8250 4.5600 -94.59%
2021 120.6560 127.5000 192.2500 72.5000 84.2500 -33.92%
2020 75.1304 59.7500 137.2500 28.7500 127.5000 131.82%
2019 77.4871 93.0000 98.7500 55.0000 55.0000 -45.00%
2018 180.4698 270.0000 312.5000 75.0000 100.0000 -60.78%
2017 180.6304 205.0000 266.2500 110.0000 255.0000 24.39%
2016 154.1082 171.2500 205.0000 87.7750 205.0000 2.50%
2015 179.1815 225.0000 235.0000 102.5000 200.0000 -9.09%
2014 268.2806 322.5000 337.5000 217.5000 220.0000 -27.87%
2013 163.9382 62.5000 335.0000 37.5000 305.0000 577.78%
2012 58.7500 62.5000 127.5000 20.0000 45.0000 -64.71%
2011 163.7391 112.5000 300.0000 52.5000 127.5000 -49.50%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.013B $0.054B
Cosmos Health is a healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices. Cosmos Health, formerly known as Cosmos Holdings Inc., is based in CHICAGO, IL.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.152B 31.57
Zoetis (ZTS) United States $75.067B 28.01
Takeda Pharmaceutical (TAK) Japan $47.697B 9.49
Daiichi Sankyo, - (DSNKY) Japan $46.849B 23.83
Sandoz Group AG (SDZNY) Switzerland $23.527B 0.00
Merck (MKKGY) Germany $17.005B 12.46
Summit Therapeutics (SMMT) United States $14.653B 0.00
United Therapeutics (UTHR) United States $14.421B 12.76
Shionogi (SGIOY) Japan $14.275B 14.30
Neurocrine Biosciences (NBIX) United States $12.332B 42.24
Orion OYJ (ORINY) Finland $10.083B 27.27
IPSEN (IPSEY) France $10.039B 0.00
Corcept Therapeutics (CORT) United States $7.318B 59.49
Stevanato Group S.p.A (STVN) Italy $7.038B 43.04
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.086B 0.00
Grifols, S.A (GRFS) Spain $5.995B 0.00
Ionis Pharmaceuticals (IONS) United States $5.609B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.791B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.093B 10.84
Crinetics Pharmaceuticals (CRNX) United States $3.026B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 19.46
BioCryst Pharmaceuticals (BCRX) United States $2.298B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.247B 12.15
NewAmsterdam Pharma (NAMS) Netherlands $2.190B 0.00
Indivior (INDV) United States $1.874B 7.95
Recursion Pharmaceuticals (RXRX) United States $1.858B 0.00
Dyne Therapeutics (DYN) United States $1.590B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.584B 0.00
Evotec AG (EVO) Germany $1.424B 0.00
Ocular Therapeutix (OCUL) United States $1.348B 0.00
Guardian Pharmacy Services (GRDN) United States $1.324B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 21.86
Harrow (HROW) United States $1.054B 0.00
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Akebia Therapeutics (AKBA) United States $0.969B 0.00
Collegium Pharmaceutical (COLL) United States $0.948B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.913B 0.00
Ardelyx (ARDX) United States $0.871B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.697B 0.00
KalVista Pharmaceuticals (KALV) United States $0.686B 0.00
Xencor (XNCR) United States $0.649B 0.00
Liminatus Pharma (LIMN) United States $0.640B 0.00
AleAnna (ANNA) United States $0.608B 0.00
Elite Pharmaceuticals (ELTP) United States $0.595B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.555B 0.00
USANA Health Sciences (USNA) United States $0.541B 11.77
Theravance Biopharma (TBPH) United States $0.539B 0.00
Bioventus (BVS) United States $0.535B 13.56
Verve Therapeutics (VERV) United States $0.511B 0.00
Tourmaline Bio (TRML) United States $0.485B 0.00
Zevra Therapeutics (ZVRA) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.456B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.450B 0.00
Altimmune (ALT) United States $0.443B 0.00
Siga Technologies (SIGA) United States $0.420B 8.78
Savara (SVRA) United States $0.411B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.375B 10.13
Organogenesis (ORGO) United States $0.365B 0.00
Aquestive Therapeutics (AQST) United States $0.355B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.267B 24.68
MediWound (MDWD) Israel $0.234B 0.00
ProKidney (PROK) United States $0.230B 0.00
Esperion Therapeutics (ESPR) United States $0.230B 0.00
Nanobiotix S.A (NBTX) France $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.181B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Lyell Immunopharma (LYEL) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
OmniAb (OABI) United States $0.169B 0.00
Larimar Therapeutics (LRMR) United States $0.158B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Avita Medical (RCEL) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Nektar Therapeutics (NKTR) United States $0.126B 0.00
Wellgistics Health (WGRX) United States $0.125B 0.00
Achieve Life Sciences (ACHV) Canada $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.095B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Unicycive Therapeutics (UNCY) United States $0.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.092B 0.00
VAXART, INC (VXRT) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.090B 14.77
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Context Therapeutics (CNTX) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Lyra Therapeutics (LYRA) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
Relmada Therapeutics (RLMD) United States $0.027B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ainos (AIMD) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.18
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00